Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|
Evidence & Research

Placebo-Controlled

Definition

A design in which the comparison arm receives placebo rather than nothing or another active agent, isolating the intervention's own contribution to whatever changed.

Terms used in this definition

Other entries this definition refers to.

Where this term comes up

Entries whose definition mentions Placebo-Controlled.

What this means for research sourcing

Understanding evidence quality helps researchers prioritize compounds. Volta's research library summarizes the literature behind stocked compounds.

Related Terms in Evidence & Research

Placebo Effect

Improvement that follows the expectation of treatment rather than the treatment itself. It is real, measurable and occasionally large, and separating it from a drug effect is the entire purpose of a control arm.

Crossover Trial

A design in which each participant receives both treatments in sequence with a washout between, so each person acts as their own control. It needs fewer participants and only suits stable, reversible conditions.

Intention-to-Treat

Analysing every participant in the arm they were randomised to, whether or not they finished. It preserves the randomisation and usually gives a more conservative answer than analysing completers only.

Endpoint

A defined, measurable outcome a trial uses to judge an intervention. Which endpoints were chosen, and when, is as informative as the results reported against them.

Primary Endpoint

The single outcome a trial was designed and powered to answer, fixed before data collection. Secondary endpoints are informative and are not what the trial succeeded or failed on, a distinction that press releases regularly blur.

Biomarker

A measurable indicator standing in for a process, a disease state or a response. Serum IGF-1 is the usual biomarker in growth hormone secretagogue work, and a biomarker moving is not the same as an outcome improving.

HbA1c (Glycated Hemoglobin)

A blood measure reflecting average glucose over roughly the preceding two to three months, reported as a percentage. It is the standard primary endpoint in metabolic trials, which is why a result quoted in points of HbA1c appears in almost every incretin paper.

Effect Size

How large the difference an intervention produced actually was, in real units or as a standardised measure. Once significance is established this is the only question left that matters.

Browse the research catalogue

Buying and verification

Your Cart

Your cart is empty

Browse our catalog to add research compounds.